Role of CDKN2C Copy Number in Sporadic Medullary Thyroid Carcinoma-Reference-Cited by-同舟云学术

Role of CDKN2C Copy Number in Sporadic Medullary Thyroid Carcinoma

Published:2016-11 Issue:11 Volume:26 Page:1553-1562
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Grubbs Elizabeth G.¹,Williams Michelle D.²,Scheet Paul³,Vattathil Selina³,Perrier Nancy D.¹,Lee Jeffrey E.¹,Gagel Robert F.⁴,Hai Tao⁴,Feng Lei⁵,Cabanillas Maria E.⁴,Cote Gilbert J.⁴

Affiliation:

1. Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.

2. Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas.

3. Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, Texas.

4. Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, Texas.

5. Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2016.0224

Reference49 articles.

1. Exomic Sequencing of Medullary Thyroid Cancer Reveals Dominant and Mutually Exclusive Oncogenic Mutations in RET and RAS

2. Cancer statistics, 2015

3. Need for a Revised Staging Consensus in Medullary Thyroid Carcinoma

4. Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial

5. Lessons learned and questions unanswered from use of multitargeted kinase inhibitors in medullary thyroid cancer

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fundamentals and recent advances in the evaluation and management of medullary thyroid carcinoma;Molecular and Cellular Endocrinology;2024-10

2. IDH1 mutation produces R-2-hydroxyglutarate (R-2HG) and induces mir-182-5p expression to regulate cell cycle and tumor formation in glioma;Biological Research;2024-05-17

3. Molecular Basis and Natural History of Medullary Thyroid Cancer: It is (Almost) All in the RET;Cancers;2023-10-05

4. p18INK4C and BRCA1 inhibit follicular cell proliferation and dedifferentiation in thyroid cancer;Cell Cycle;2023-06-22

5. The Oncogenic Role of Cyclin-Dependent Kinase Inhibitor 2C in Lower-Grade Glioma;Journal of Molecular Neuroscience;2023-05-24